Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1995
06/29/1995WO1995017093A1 New cryptophycins
06/29/1995WO1995015161A3 Medicament for treating heart insufficiency
06/29/1995WO1995014011A3 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
06/29/1995WO1995011013A3 Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women
06/29/1995DE4345266A1 New isoquinolone or phthalazinone carboxylic acid ester and derivs.
06/29/1995DE4344697A1 New lotion is water-oil emulsion compsn. contg. corticosteroid
06/29/1995DE4344661A1 New citronellyl, geranyl, farnesyl, phytyl or iso-phytyl ester cpds
06/29/1995DE4344645A1 Anti-retroviral agent, esp. for treatment of AIDS
06/29/1995DE4334927C1 Use of lithium salts
06/29/1995CA2187296A1 Indole derivatives as anti-estrogens
06/29/1995CA2179735A1 N-oxides of 4-arylpiperazines and 4-arylpiperidines as antipsychotic drugs
06/29/1995CA2179649A1 Use of pla2 inhibitors as treatment for alzheimer's disease
06/29/1995CA2179492A1 A method of treating gastrointestinal motility disorders
06/29/1995CA2179491A1 A method of treating gastrointestinal motility disorders
06/29/1995CA2179490A1 New cryptophycins
06/29/1995CA2179402A1 Indoline derivatives, method of preparation and their use as pharmaceuticals
06/29/1995CA2179399A1 4,5-diaryloxazole derivatives
06/29/1995CA2179288A1 Vitamin d3 analogues and pathway to mediate disorders
06/29/1995CA2179282A1 Pharmaceuticals
06/29/1995CA2179067A1 Polymorphs of losartan and the process for the preparation of form ii of losartan
06/29/1995CA2178833A1 Phenylthiophenyl cycloalkenyl hydroxyureas as lipoxygenase inhibitors
06/29/1995CA2178811A1 Anti-hepatitis b viral oligonucleotides
06/29/1995CA2178745A1 A novel tumor suppressor gene
06/29/1995CA2178735A1 Mediators of chronic allograft rejection
06/29/1995CA2178310A1 Laxative compositions containing bulk fiber and dioctyl sulfosuccinate
06/29/1995CA2178209A1 Anellated dihydropyridines and the use thereof for preparing pharmaceutical preparations
06/29/1995CA2178094A1 New pyridazino[4',5':3,4]pyrrolo-[2,1-a]isoquinolines and their use for preparing pharmaceutical compositions
06/29/1995CA2178088A1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations
06/29/1995CA2177851A1 Heterocyclic compounds
06/29/1995CA2176130A1 Non-peptide tachykinin receptor antagonists
06/29/1995CA2176127A1 Methods for the treatment or prevention of conditions associated with amyloidogenic reptides
06/29/1995CA2156396A1 Stable dermatologic preparation containing mycophenolic acid
06/29/1995CA2155098A1 Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents
06/29/1995CA2155096A1 2,2'-bi-1h-pyrrole derivates with immunomodulating activity
06/29/1995CA2138631A1 6,8 dioxabicyclo¬3.2.1|octanes as inhibitors of leukotriene biosynthesis
06/29/1995CA2138305A1 Tumor necrosis factor production inhibitors
06/28/1995EP0659761A2 New 17-iminomethylalkenyl-5beta-14beta-androstane and 17-iminoalkyl-5beta-14beta-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
06/28/1995EP0659755A1 Phospholipids as vectors for active molecules, their preparation and their use in cosmetic or dermatologic compositions
06/28/1995EP0659752A1 Novel substance dc114-a1
06/28/1995EP0659748A1 Substituted 1-oxo-1,2-dihydro-isoquinolinoyl-and 1,1-dioxo-2H-1,2-benzothiazinoylguanidines, process for their preparation, their use as medicament or diagnostic agent, as well as a medicament containing them
06/28/1995EP0659747A1 Branched aminothiazole derivatives process for their preparation and pharmaceutical compositions containing them
06/28/1995EP0659737A2 Catecholamine surrogates useful as B3 agonists
06/28/1995EP0659436A1 A potentiator for interferon and an antiviral activity-potentiating composition containing interferon and its potentiator
06/28/1995EP0659435A1 Injectable ready-to-use solutions containing an antitumour anthracycline glycoside
06/28/1995EP0659434A1 Use of phosphoric and phosphonic acid esters for the treatment of cerebral insufficiency disorders and depressions
06/28/1995EP0659433A1 Ophthalmic suspension containing diflupredonate
06/28/1995EP0659432A1 Sugar-coated pharmaceutical dosage unit
06/28/1995EP0659431A1 Oncogene function-inhibitory alkaloid from Ervatamia microphylla
06/28/1995EP0659430A1 Use of benzo[g]quinolines in the treatment of glaucoma and for the prevention of progressive atrophy of the optic nerve
06/28/1995EP0659429A1 Raloncifene for inhibiting fertility in women
06/28/1995EP0659428A1 2-Phenyl-3-azoylbenzothiophenes for treating obsessive-compulsive and consumptive disorders
06/28/1995EP0659427A1 2-Phenyl-3-azoylbenzothiophenes for increasing thombomodulin expression
06/28/1995EP0659426A1 2-Phenyl-3-azoylbenzothiophenes for treating pulmonary hypertensive diseases
06/28/1995EP0659425A1 2-Phenyl-3-azoylbenzothiophenes for increasing macrophage function
06/28/1995EP0659424A1 2-Phenyl-3-azoylbenzothiophenes for treating male infertility
06/28/1995EP0659423A1 2-Phenyl-3-azoylbenzothiophenes for inhibiting weight gain or inducing weight loss
06/28/1995EP0659422A1 2-Phenyl-3-azoylbenzothiophenes for treating Turner's syndrome
06/28/1995EP0659421A1 2-Phenyl-3-azoylbenzothiophenes for treating menstrual symptoms
06/28/1995EP0659420A1 2-Phenyl-3-azoylbenzothiophenes for treating sexual precocity
06/28/1995EP0659419A1 2-Phenyl-3-azoylthiophenes for inhibiting breast disorders
06/28/1995EP0659418A1 2-Phenyl-3-azoylbenzothiophene for treating Alzheimer's disease
06/28/1995EP0659417A2 Inhibition of dysfunctional uterine bleeding
06/28/1995EP0659416A2 Inhibition of seborrhea and acne
06/28/1995EP0659415A2 Inhibition of vasomotor symptoms and treatment of psychological disturbances surrounding post-menopausal syndrome
06/28/1995EP0659414A2 Inhibition of hirsutism and alopecia in women
06/28/1995EP0659413A2 Inhibition of CNS problems in post-menopausal women
06/28/1995EP0659412A2 Inhibition of the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder
06/28/1995EP0659411A2 Method for increasing libido in post-menopausal women
06/28/1995EP0659410A2 Use of the compound flupirtin against muscle bracing
06/28/1995EP0659409A2 Substance 1 antagonists for the inhibition of angiogenesis
06/28/1995EP0659408A1 Use of R(+)alpha-lipoic acid, R-(-)dihydrolipoic and metabolites for the treatment of diabetes mellitus and its resulting disorders
06/28/1995EP0659407A1 Pharmaceutical compositions containing pyrylium compounds, pyrylium salts and process for manufacturing a medicament containing the aforesaid compounds
06/28/1995EP0659402A2 Formulations containing carotenoids and procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals
06/28/1995EP0659401A1 Semi-paste oral preparations comprising povidone-iodine, potassium iodide and a sugar alcohol
06/28/1995EP0659349A1 Treatment of diabetes by administration of myo-inositol
06/28/1995EP0659341A1 Solid insecticidal formulation
06/28/1995EP0659216A1 Retroviral vector for the transfer and expression of genes for therapeutical purposes in eucaryotic cells
06/28/1995EP0659211A1 Methods and therapeutic compositions for treating cystic fibrosis
06/28/1995EP0659209A1 Cancer therapy utilizing malignant cells
06/28/1995EP0659193A1 Platelet aggregation inhibitors
06/28/1995EP0659185A1 Novel isoindolinone derivative, its preparation and pharmaceutical compositions containing same
06/28/1995EP0659183A1 Heteroaryl compounds used as pharmaceuticals
06/28/1995EP0659182A1 Piperazine derivatives and salts thereof
06/28/1995EP0659181A1 Sulfonamide inhibitors of hiv-aspartyl protease
06/28/1995EP0659180A1 Anti-viral sulfur-analogues of 1,5-dideoxy-1,5-imino-d-glucitol (deoxynojirimycin)
06/28/1995EP0659179A1 Benzo-fused lactams promote release of growth hormone
06/28/1995EP0659177A1 4-oxo-azetidine-2-sulphonic acid amides and their salts, process for their production and their use
06/28/1995EP0659174A1 Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants
06/28/1995EP0659172A1 Analogues of vpa used as anti-epileptica.
06/28/1995EP0659083A1 Prevention and treatment of peripheral neuropathy
06/28/1995EP0659082A1 Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine
06/28/1995EP0659081A1 Dexpanthenol-containing plaster for the transdermal application of steroid hormones
06/28/1995EP0659080A1 Method and composition for the treatment of hair loss
06/28/1995EP0659079A1 Transdermal therapeutic system with pentylene tetrazol as active substance.
06/28/1995EP0659078A1 Anabaseine derivatives useful in the treatment of degenerative diseases of the nervous system
06/28/1995EP0659077A1 Controlled release pilocarpine delivery system
06/28/1995EP0659076A1 7-((substituted)amino)-8-(((substituted)carbonyl)-methylamino)-1-oxaspiro(4,5)decanes useful in parkinson's disease, dystonia, and other movement disorders
06/28/1995EP0659073A1 Biodegradable polymer matrices for sustained delivery of local anesthetic agents
06/28/1995EP0659072A1 Pharmaceutical emulsions containing bioactive steroids
06/28/1995EP0613370B1 Prolonged release diltiazem-based formulation
1 ... 7006 7007 7008 7009 7010 7011 7012 7013 7014 7015 7016 7017 7018 7019 7020 7021 7022 7023 7024 7025 7026 ... 7860